Want to track BLTE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Belite Bio, Inc. (BLTE) Statistics
Valuation metrics
Market Cap 5.99B
Enterprise value 6.02B
Trailing P/E (ttm) -58.85
Forward P/E -
PEG ratio 1.09
Price/Sales (ttm) -
Price/Book (mrq) 7.52
Enterprise Value/Revenue -
Enterprise Value/EBITDA -62.94
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 233.19K
Average volume (90 days) 162.1K
Price summary
52-Week low 59.12
52-Week high 200
Beta -
50-Day moving average 146.68
200-Day moving average 163.46
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.11%
Return on equity -0.18%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.26
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 12.35
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 33.71%
Book value per share (mrq) 19.96
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
